Haemonetics
HAE
#3438
Rank
โ‚น360.45 B
Marketcap
โ‚น7,482
Share price
-1.02%
Change (1 day)
6.55%
Change (1 year)

Revenue for Haemonetics (HAE)

Revenue in 2025 (TTM): โ‚น114.78 Billion

According to Haemonetics's latest financial reports the company's current revenue (TTM ) is โ‚น119.58 Billion. In 2024 the company made a revenue of โ‚น117.82 Billion an increase over the revenue in the year 2023 that were of โ‚น105.74 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Haemonetics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น114.78 B-2.59%
2024 โ‚น117.82 B11.43%
2023 โ‚น105.74 B13.16%
2022 โ‚น93.44 B31.71%
2021 โ‚น70.94 B9.75%
2020 โ‚น64.64 B-9.28%
2019 โ‚น71.25 B7.07%
2018 โ‚น66.55 B16.02%
2017 โ‚น57.36 B-6.24%
2016 โ‚น61.18 B3.11%
2015 โ‚น59.34 B1.23%
2014 โ‚น58.62 B0.16%
2013 โ‚น58.52 B28.99%
2012 โ‚น45.37 B20.6%
2011 โ‚น37.62 B24.25%
2010 โ‚น30.28 B3.8%
2009 โ‚น29.17 B3.89%
2008 โ‚น28.08 B44.66%
2007 โ‚น19.41 B-1.08%
2006 โ‚น19.62 B6.54%
2005 โ‚น18.41 B11.53%
2004 โ‚น16.51 B4.42%
2003 โ‚น15.81 B-1.58%
2002 โ‚น16.07 B4.54%
2001 โ‚น15.37 B14.8%
2000 โ‚น13.39 B9.04%
1999 โ‚น12.28 B11.56%
1998 โ‚น11.00 B-9.23%
1997 โ‚น12.12 B13.63%
1996 โ‚น10.67 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น3.938 T 3,193.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
โ‚น2.195 T 1,736.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚น1.925 T 1,510.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus
CERS
โ‚น17.93 B-85.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚น992.69 B 730.14%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น302.36 B 152.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.298 T 6,839.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚น3.079 T 2,475.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland